Teva  picture: Bloomberg Teva launches asthma product with generic version

Teva's AirDuo RespiClick and its generic equivalent will compete against GSK's Advair which has annual sales of $2 billion.

drug development Drug delivery co SteadyMed raises $30m

The company's leading drug candidate is Trevyent for the treatment of Pulmonary Arterial Hypertension (PAH).

Mannkind execs open TASE trading MannKind restructures debt to Deerfield

Since listing in Tel Aviv in 2015, US pharmaceuticals company MannKind has lost 95% of its value.

Suzana Nahum-Zilberberg BioLight to sell IOPtima to Chinese co

BioLight will sell its stake in IOPtima in installments at a company value of $30-56 million.

Biomed (Illustration: Shutterstock) Israeli co MeMed wins $9.2m Pentagon contract

MeMed accurately distinguishes between bacterial and viral infections based on the patient immune response.

Aspect Imaging Photo: Company Website Israeli MRI co Aspect Imaging raises $30m

The relatively small size of Aspect’s MRI technology platform enables systems to be placed at the Point-of-Care.

Health Photo: Shutterstock ASAP Creative Healthcare meets big data

"Globes" profiles the 10 Israeli startups in the Reboot Forum 2017’s Leading Healthcare Initiative, presenting innovations based mainly on big data analytics.

Zvi Marom  photo: Eyal Izhar "Then I got this crazy idea: Hire Bibi"

BATM's Zvi Marom reminisces about when the prime minister worked for him, and offers tips for his current job.

Amit Goffer UPnRIDE Photo: Company website UPnRIDE lets wheelchair users stand and ride

Having set up ReWalk to help those paralyzed below the waist, Amit Goffer's new startup will also help those with upper body paralysis, including himself.

Prof. Yitzhak Haviv Photo: Amir Meiri "Sometimes saving lives justifies crony capitalism"

Bar-Ilan University biologist Prof. Izhak Haviv insists personalized medicine to cure cancer in affluent people will help all patients.

dentistry image: Shutterstock/ASAP Creative Israeli dental tech cos lead in implant innovations

Poalim Capital Markets: We want to help the Israel medical market mature into a global leader.

Erez Vigodman Photo: Eyal Yizhar Teva's outgoing CEO earned NIS 20m in 2016

Teva's five highest-paid executives earned an aggregate $25 million.

Teva Teva campus construction to continue despite cost

The Ra'anana campus will house Teva's headquarters, laboratories, and production facilities.

Erez Vigodman, Benny Landa Photos: Eyal Yizhar Landa: Teva needs CEO with pharma background

Activist shareholder Benny Landa thinks Teva should be split into generics and branded drugs companies.

Arie Belldegrun Photo: PR "Teva slow to prepare for life after Copaxone"

Kite Pharma CEO Arie Belldegrun, who resigned from Teva's board: Teva's pipeline provides sufficient infrastructure to make it a significant innovative player.

Erez Vigodman photo: Eyal Yitzhar Debt weighs on Teva

On top of all its other woes, the Israeli pharmaceutical giant has a net debt of $35 billion, higher than its $32 billion market cap.

Twitter Facebook Linkedin RSS Newsletters גלובס Capital  Markets Conference 2017